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Simple Summary: Salmonellosis is one of the most severe zoonotic diseases transmitted to humans
through animal products (especially poultry meat and eggs). Essential oils (EOs)-based feed additives
in poultry nutrition are a possible alternative replacement of antimicrobials to fight this infection.
In the present study on laying hens, we tested a phytobiotic, Intebio®, and elucidated formation of
immune response and changes in cecal microbiocenosis and biochemical/immunological variables
in blood caused by Salmonella. Changes in differential gene expression were observed at both
one and seven days post-inoculation in the hens’ intestines, revealing similarities with known
mammalian/human tissue-specific expression. The results of this study suggest that the challenge
of birds with Salmonella had a negative effect, while phytobiotic intake had a positive effect on the
status of their gastrointestinal microbiome, their level of metabolism, and their performance.
Abstract: One of the main roles in poultry resistance to infections caused by Salmonella is attributed
to host immunity and intestinal microbiota. We conducted an experiment that involved challenging
Lohmann White laying hens with Salmonella Enteritidis (SE), feeding them a diet supplemented
with an EOs-based phytobiotic Intebio®. At 1 and 7 days post-inoculation, the expression profiles
of eight genes related to immunity, transport of nutrients in the intestine, and metabolism were
examined. Cecal microbiome composition and blood biochemical/immunological indices were also
explored and egg production traits recorded. As a result, the SE challenge of laying hens and Intebio®
administration had either a suppressive or activating effect on the expression level of the studied
genes (e.g., IL6 and BPIFB3), the latter echoing mammalian/human tissue-specific expression. There
were also effects of the pathogen challenge and phytobiotic intake on the cecal microbiome profiles
and blood biochemical/immunological parameters, including those reflecting the activity of the birds’
immune systems (e.g., serum bactericidal activity, β-lysine content, and immunoglobulin levels).
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Significant differences between control and experimental subgroups in egg performance traits (i.e.,
egg weight/number/mass) were also found. The phytobiotic administration suggested a positive
effect on the welfare and productivity of poultry.
Keywords: essential oils-based phytobiotic; Salmonella enterica serovar Enteritidis; gene expression;
cecum microbiome; blood biochemical/immunological parameters; laying hens
1. Introduction
Contamination with Salmonella affects an estimate of 20% of poultry meat [1]. This
pathogen has the ability to remain viable for considerable periods of time in various
biological and nonbiological habitats due to the formation of biofilms. Salmonella spp. are
widely represented in the environment, and the intestinal tract of animals and birds is
where they are found most [2,3]. Salmonella enterica can cause severe zoonotic disease and
is transmitted to humans via raw animal products, including poultry meat and eggs [4,5].
Intestinal microbiota plays one of the dominant roles in the resistance of chickens to
Salmonella infections [6]. Its composition correlates to a large extent with the responsiveness
to gastrointestinal diseases caused by pathogens [7,8]. It can also reflect inflammatory pro-
cesses, an influx of phagocytes and lymphocytes from the circulatory system, an increase in
the amount of pathogenic microflora, and its toxin-producing activity. Symbiotic intestinal
microbiota in chickens has long been considered as a separate multifunctional “organ”
that is very important in the functioning of the whole organism, influencing health and
performance [9]. Birds have such a peculiar feature of digestive system as the lowest rate
of passage of the chyme in cecum, compared with the other intestinal parts, which creates
an ideal environment for the propagation of various microorganisms.
Disturbance in the composition of the intestinal microflora in birds due to antibiotic
therapy significantly increases their susceptibility to S. enterica [10,11]. This highlights the
need to search for and develop feed additive alternatives to antibiotics. Apart from the use
of antibiotics, an important way to prevent bacterial diseases is to modulate the intestinal
protection using feed ingredients or prebiotics [12–14]. In recent years, evidence has ac-
cumulated that essential oils (EOs) can be effective natural immunomodulators [15–17].
Plant EOs are terpenes and terpenoids, as well as aromatic and aliphatic compounds [18].
Some phenolic compounds and terpenes have been reported to have anti-inflammatory
activity [19,20]. The antimicrobial property of several plant-derived EOs has been demon-
strated against gram-negative and gram-positive bacteria [21], including S. enterica serovar
Enteritidis (SE) [22,23]. It was also noted that the addition of phytochemicals to feed
had a positive effect on the secretion of pancreatic and intestinal enzymes in broilers [24].
It promoted nutrient absorption and improved feed conversion in poultry [25]. Many
ingredients in the composition of EOs are generally recognized as safe (GRAS) compounds
permitted by the U.S. Food and Drugs Administration when used for feed purposes [26].
When intestinal pathogens, including SE, enter the host organism, they are able to
modulate the hosts’ transcriptional program [27,28]. Recognition of a pathogen is a complex
process, triggers subsequent changes in the expression levels of many host genes, and
depends on a number of factors, such as the host genotype, its immunological status,
dietary factors, etc.
The epithelial membrane in the intestines not only protects the host from pathogens
present in the intestinal lumen but, also, performs the function of absorbing nutrients
through numerous ion channels and transporters present on the apical intestinal epithelial
border. Microbial infections can affect the transport of ions in the intestines. This depends
on such factors as host immunity, virulence of pathogenic microorganisms, structural
organization of the mucous membrane of a particular segment of the intestines, and age
of the animal [6,29,30]. Due to infection with pathogens, the functional disruption of ion
transporters, such as cystic fibrosis transmembrane conductance regulator (CFTR) and
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epithelial Na+/H+ exchanger SLC9A3 [29,30], can result in diarrhea, malabsorption, and
inflammation of the intestine [31]. This leads to lower efficiency in the production of
poultry produce.
In chickens, Salmonella recognition in the cecum initially occurs by means of Toll-like
receptors (TLR) [32]. This is followed by the subsequent induction of genes associated
with the synthesis of chemokines, cytokines, and effector genes that form the basis of
the innate immune system. It leads to the infiltration of heterophiles, macrophages, and
B and T lymphocytes [33,34]. It also has been found in chickens that such cytokines as
interleukin-1β (IL1B), interleukin-6 (IL6), interleukin-17 (IL17A), interleukin-22 (IL22), and
others contribute to the development of the inflammatory response. The main function
of other peptides, chemokines, is to regulate the movement of leukocytes. In the chicken
genome, a number of genes associated with chemokine synthesis have been identified, one
of them being IL8L1 (K60 or CXCLi1), involved in signaling between immune cells [35].
Antimicrobial peptides called defensins also contribute to counteracting infections
caused by Salmonella spp. [36,37]. They embrace three main groups of α-, β-, and θ-
defensins [38–40]. While α-defensins were found only in mammals [38] and θ-defensins in
all vertebrates [41], β-defensins (or gallinacins), such as AvBD1 (Gal-1 and Gal-1α), AvBD2
(Gal-2), AvBD4 (Gal-4), AvBD10 (Gal-10), and others [41–44], are specific to birds, including
chickens. These antimicrobial peptides influence pathogenic microbes by interacting with
the negatively charged phospholipid bilayer in the cell membrane, which leads to the
destruction of bacterial cells [42]. It was also suggested that β-defensins in birds exhibit
a more pronounced efficacy against Gram-positive bacteria than Gram-negative bacteria
because of their structural conformation [45]. The expression of genes associated with
the synthesis of β-defensins has been observed in various organs and tissues in chickens,
including intestinal epithelial cells [46].
To date, the available information about the immune reaction in birds in response
to S. enterica–related lesions is contradictory and does not give a clear indication as to its
formation and manifestation. In addition to observations that the infection of chickens
with Salmonella is, as a rule, characterized by the induction of an inflammatory response
and upregulation of many genes, it was noted that the expression level of some other genes
can be reduced due to infection with this pathogen [47]. In particular, the infection of
five-month-old chickens with SE resulted at 10 days post-inoculation (dpi) in the downreg-
ulation of 32 various genes in the liver. These genes mainly belonged to two functional
categories: the control of metabolic functions and the cell cycle. The greatest reduction of
expression was found for some genes, including CALB1, associated with the synthesis of
calbindin 1 [47].
The challenge of laying hens with Salmonella has long been shown to have a negative
impact on egg production [48,49]. In addition, the effect of the pathogen on the blood
parameters of birds was studied [50]; however, data on the effect of SE on the expression
of immunity and productivity genes are limited. Therefore, further research is needed
to explore the expression of these and other genes related to resistance, metabolism, and
productivity in response to Salmonella infection in hens.
There are also homologous genes not only in birds but, also, in other amniotes and
humans that are over- or under-expressed in the gastrointestinal tract (GIT), including
the vermiform appendix and intestine [51]. These include IL6, IL8, and CALB1, as well as
SLC5A1 (solute carrier family 5 member 1), CA2 (carbonic anhydrase 2), RARRES1 (retinoic
acid receptor responder 1), and BPIFB3 (BPI fold containing family B member 3). SLC5A1
is part of the glucose (GLUC) carrier family [52]. CA2 participates in many processes, with
the gene expression also found in the intestines. In addition, the chicken homolog also
affects eggshell calcification [53]. RARRES1 and BPIFB3 are involved in the regulation of
endopeptidase activity and innate immune response, respectively, and are also associated
with the synthesis of eggshell proteins [54–57]. It would therefore be of great interest to
clarify the effects of infection and phytogenic dietary supplementation on the functioning
of these genes in the chicken cecum.
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Important indicators characterizing the level of metabolic processes and the overall
functional state of the body are certain elements and properties of the blood. Change
in number of formed elements in the blood is due to certain paratypical factors whose
descriptions facilitate understanding the state and dynamics of the main physiological
functions of the organism, especially when it is infected with pathogenic microflora. For
example, an increased activity of alanine aminotransferase (ALT) in the blood of layer
chickens was previously shown to be due to infection with Salmonella [58,59].
When developing preventive measures to combat Salmonella, it should be borne in
mind that the basis of the contemporary concept to fight against pathogens would be the
optimization of microecological niches in ecosystems, which should take into account
the principle of self-regulation [60,61]. The search for natural environmentally friendly
biopreparations based on EOs that would improve the body’s resistance and restore the
normal composition of the microbiome seems to be a timely objective. One of such drugs
can be a newly developed phytobiotic Intebio® (BIOTROF+ Ltd., Pushkin, St Petersburg,
Russia), the effectiveness of which was previously shown in swine nutrition [62,63]. Re-
cently, we also tested the efficacy of this supplement in feeding and treating Ross 308 broiler
chickens [64].
Although differential gene expression (DGE) in chickens in response to infection with
SE was the focus of a number of recent studies [65–67], it is relevant to conduct an in-depth
examination of the effects of infection on a complex of characteristics, including profiles
of the cecal microbiome and regulation of the genes involved in immunity, transport, and
metabolism. It is also important to conduct further investigations on the dynamics of shifts
in the blood biochemical/immunological parameters and, from a practical perspective,
on testing the phytobiotics such as Intebio® for improving the immune response and
performance. This would have the ultimate aim of preventing bacterial disease in poultry.
In this regard, the aim of the present study was to examine the composition of the
cecal microbiome. Specifically, the expression of genes related to immunity, transport,
and metabolism; blood biochemical/immunological indices; and egg production traits in
laying hens in response to the challenge with SE, as well as the administration of Intebio®,
a relatively novel experimental supplement derived from EOs. A better understanding of
the reaction of the microbial community, as well as the function of genes associated with
immunity, transport, and metabolism can help in clarifying the mechanisms of the adaptive
response of chickens to Salmonella infection. Based on the knowledge gained, it would be
feasible to develop further strategies aimed at improving the functional status, nutrition,
welfare, and, ultimately, performance of layer chickens, which could make an essential
contribution to the improved practices of the poultry industry.
2. Materials and Methods
2.1. Experimental Design and Sampling
The experimental protocol was set up according to the European Convention for the
Protection of Vertebrate Animals used for Experimental and other Scientific Purposes,
ETS No 123 and was authorized by the relevant national authority. The experiment was
carried out using Lohmann White hybrid laying hens kept in a vivarium of the All-Russian
Veterinary Research Institute of Poultry Science (ARVRIPS). Details on the conditions of
keeping and feeding of the birds, as well as their vaccinations and welfare, are provided in
the Supporting Information (SI) File S1.
The beginning of the experimental period and data collection in 80 chickens cor-
responded to 346 days of age when birds were randomly divided into two groups of
40 animals in each group. Group I (control) received a normal diet, while birds in Group II
were fed a diet supplemented with Intebio® (BIOTROF+ Ltd.) [62,63] once a day (at 9 a.m.)
and in amount of 90 g per ton of feed, according to the manufacturer’s instructions for
preparation use. Intebio® is a feed additive with the properties of phytobiotics (Technical
Specification No. TU 9362-011-50932298-2011; Registration No. PVR-2-7.11/02755) that
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contains a carrier (wheat bran; GOST 7169-2017), on which a mixture of EOs (derived from
garlic, lemon, thyme, and eucalyptus) was applied.
At the age of 367 days, each group of birds was randomly divided into two equal
subgroups, and half of them were challenged with an epizootic SE strain, so that four
subgroups of 20 hens each were formed as follows: S-I, negative control subgroup fed
normal diet and not challenged, S-II, control + SE challenge, S-III, Intebio® intake, and S-IV,
Intebio intake + SE challenge (SI File S1).
In the experiment, the strain SE 25–87 was used that was obtained from the ARVRIPS
collection and isolated in 2012 from the chicken cecum. To extract the strain isolate, a
sample of the chicken cecal contents was placed in a sterile physiological solution at the
ratio 1:1000 and homogenized, and 3 to 4 drops of the solution were then added to a
tube with a culture medium. Incubation was conducted for 24 h at 35 ◦C. For the strain
culturing, the Rappaport medium (Salmonella enrichment broth; Merck KGaA, Darmstadt,
Germany) was used. The medium composition included the following components (in
g/l): casein peptone, 5.0, sodium chloride, 8.0, disubstituted potassium phosphate, 0.8,
hexavalent magnesium chloride, 40.0, and malachite green, 0.12. Prior to culturing, 54 g
of Rappaport dry magnesium medium was dissolved in 1 liter of distilled water and
autoclaved for 20 min at 115 ◦C to ensure that the cooled medium had pH = 6.0 ± 0.2
at 25 ◦C. Taxonomic affiliation of the SE bacterium strain was verified using cultural
morphological tests following the appropriate guidelines for the salmonellosis diagnosis
procedure [68].
Challenge of the hens in S-II and S-IV was executed at 10 a.m. with the liquid culture
of the SE strain in the amount of 8.69 lg colony-forming units (CFU) intramuscularly in the
pectoral muscle using the standard technique [69] in order to trigger an immune response
as ordinarily expected by an intramuscular vaccination. Prior to challenge, the bacterial
strain was cultured overnight in the Rappaport medium at 35 ◦C. Nonchallenged chickens
of S-I and S-III were injected with a similar volume of saline.
Presence of the inflammatory process in birds when infected with a pathogen was
considered unambiguous if plasma concentrations of nitrite and N-nitroso compounds were
more than 100 nM. An enzyme sensor was used to analyze nitrite and nitroso compounds
in the blood of birds [69]. Additionally, to confirm the challenge of chickens with Salmonella,
the pathological material of the intestines was plated on Modified Semisolid Rappaport-
Vassiliadis Agar (Biokar Diagnostic, Allonne, France), cultured, and then analyzed using a
rapid latex agglutination test (Salmonella Test Kit, Oxoid, Basingstoke, UK).
Challenged hens of S-II and S-IV were housed in separate boxes (as described in SI
File S1). In the course of the experiment, the number of laid eggs and egg weight were
recorded daily in the four subgroups over 27 days. Afterwards, values of the following
three egg production traits were calculated in each subgroup: mean egg weight, w, total
number of laid eggs, N, and egg mass, W, determined as the product of W = wN and equal
to the total weight of laid eggs in a subgroup.
Samples for molecular biological studies and evaluation of the blood biochemi-
cal/immunological parameters were taken from randomly selected birds in the four sub-
groups at two experiment time points: 1 and 7 dpi. Sampling was performed under the
condition of strict adherence to sterility, and euthanasia of birds was performed directly
prior to obtaining samples for molecular biological studies. Samples from challenged and
nonchallenged hens were collected in two different isolated laboratory rooms. The number
of replications was three birds in each subgroup and on each day of sampling.
Chicken cecal tissues were sampled for analyzing DGE, and cecum contents were
collected for microbiome examination. To determine blood biochemical/immunological
indices, blood was taken from the wing vein of the chickens.
2.2. Gene Expression Analysis
DGE was assessed at 1 and 7 dpi by quantitative RT-PCR, its preliminary step being
RNA extraction. Total RNA was isolated from samples using the Aurum™ Total RNA Mini
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Kit (Bio-Rad, Hercules, CA, USA). The tissue was ground by mixing with liquid nitrogen
and homogenized, followed by the steps as prescribed in the manufacturer’s instructions.
Reverse transcription reaction was conducted to produce cDNA using RNA template and
the iScript™ Reverse Transcription Supermix (Bio-Rad) [70].
To analyze DGE, specific gene primers were selected for the following eight genes:
AvBD10, IL6, IL8L1, SLC5A1, CA2, CALB1, RARRES1, and BPIFB3 (see their details and
primers in SI Table S1). Amplification reactions were performed using the SsoAdvanced™
Universal SYBR® Green Supermix (Bio-Rad) following the manufacturer’s protocols (as
outlined in [71]). Estimation of the relative DGE was done using the 2−∆∆CT method [72]
and the β-actin gene (ACTB) as a reference gene.
2.3. Analysis of Blood Biochemical/Immunological Variables
Laboratory testing of blood samples was carried out at the St. Petersburg State
Academy of Veterinary Medicine to assess the contents of 25 various biochemical/immuno-
logical parameters (see their full listing in SI Tables S2 and S3) at 1 and 7 dpi.
Protocols (as compiled in [73]) were followed to determine the serum lysozyme activ-
ity (SLA) using a photoelectric colorimetric method (including the changed temperature
regime for reaction of the chicken blood serum with Micrococcus lisodecticus), serum bacteri-
cidal activity (SBA), and serum β-lysine activity (BLA) using a photoelectric colorimetric
method. The discrete sedimentation method [74] was exploited to detect immunoglobulin
levels of the classes IgA, IgM, IgG1, and IgG2.
2.4. Next-Generation Sequencing (NGS) of Bacterial Community Profiles
To explore metagenomic profiles of the bacterial community in the cecum of laying
hens at 1 and 7 dpi, NGS technology was employed using total bacterial DNA. The
latter was extracted from the cecal content samples using the Genomic DNA Purification
Kit (Thermo Fisher Scientific Inc., Waltham, MA, USA) according to the manufacturer’s
instructions.
Amplification for the subsequent NGS was performed using a Verity thermal cycler
(Life Technologies, Inc., Carlsbad, CA, USA) and the following eubacterial PCR primers (In-
tegrated DNA Technologies, Inc., Coralville, IA, USA): 343F (5′-CTCCTACGGRRSGCAGCA
GAG-3′) and 806R (5′-GGACTACNVGGGTWTCTAAT-3′) flanking the V1V3 region of
the 16S rRNA gene. Metagenomic sequencing was performed using a MiSeq genomic
sequencer (Illumina, Inc., San Diego, CA, USA) and MiSeq Reagent Kit v3 (Illumina, Inc.).
Read libraries with a total of 57,229 and 82,645 sequences were produced using samples
collected at 1 and 7 dpi, respectively. Minimum, average, and maximum read lengths for 1-
and 7-dpi samples were 188, 246.37 ± 3.58, 251 and 188, 239.60 ± 17.75, and 251 base pairs,
respectively. Chimeric sequences were excluded from the analysis using the USEARCH
7.0 program [75]. Processing of the obtained reads was carried out using the CLC Bio GW
7.0 bioinformatics platform (Qiagen, Venlo, The Netherlands) and included overlapping,
quality filtering (QV > 15), and primer trimming. Taxonomic affiliation of microorganisms
up to the genus level was determined using the RDP Classifier program [76].
2.5. Mathematical and Statistical Analyses
Variance analysis (as described in [77]) was employed for the mathematical and
statistical analysis of the data using Excel XP/2010-based computation, and mean values
were compared using Tukey’s honestly significant difference (HSD) test and the TukeyHSD
function in the R Stats Package [78].
Using the studied biochemical/immunological indices, cluster analysis of the four
subgroups was performed by building a matrix based on squared Euclidean distances
between objects at the two time points. For matrix aggregation, the Ward’s hierarchical
agglomerative clustering was applied [79], and bootstrapping validation was performed
using 1000 iterations. Alternatively, the Unweighted Pair Group Method with Arithmetic
mean (UPGMA) method with bootstrapping validation was used on a matrix of Euclidean
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distances between objects. To calculate approximately unbiased (AU) p-values and boot-
strap probability (BP) values, the pvclust software package for R was used [80]. Clusters
with AU values more than 95% were considered as significant ones. For interpretation,
the optimal number of clusters was chosen using the Elbow method [81] and factoextra
package for R [82].
For the biodiversity analysis of cecal bacterial communities in laying hens within
samples, the parameters of their alpha diversity were determined, which characterizes
the abundance of species within communities [83]. In particular, microbiota diversity in
the chicken cecum in the four subgroups was evaluated using the direct count of taxa,
i.e., operational taxonomic units (OTUs), as well as Shannon index in the Past software
program [84,85]. The Shannon (entropy) index (H), meant to quantify the accumulation
of entropy (uncertainty or content of information) in a complex community and ranges
between 0 for one-taxon communities to higher values for multiple-taxa communities (each









where H is the diversity (in bits), and ni/n is the proportional abundance of the species
computed as number of individuals of a species (ni) divided by the total number of
individuals found (n).
Due to the fact that the values of biological diversity parameters vary according to
the number of sequenced reads in each sample, reflecting the depth of sequencing, we
evaluated the diversity using normalized data for the smallest number of sequences present
in a sample.
In addition, beta diversity, i.e., diversity between samples/communities/habitats,
or the degree of change in species composition by gradients [83], was evaluated. For
this purpose, we examined the microbial diversity of the samples using the principal
components analysis (PCA) as implemented in the EMPeror tool [87], Weighted UniFrac
metric [88], and the QIIME software package [89]. Using the cecal microbiome profiles at
the two time points, we also exploited the Ward’s hierarchical agglomerative clustering [79].
Furthermore, diversity of the chicken cecal metagenomic communities at the level
of orders and higher taxonomic ranks was also evaluated graphically in the form of a
heat map. Construction of the microbiome profile heat map was based on a phylogenetic
matrix of grouped samples using the Plotly package for R [90]. Biodiversity of the cecal
microbiome of laying hens at lower taxonomic levels was assessed using the MEGAN
program, version 6.15.2 [91], and log-normalized data were used to plot the graphs.
To estimate relationships between treatments and studied characters in the subgroups,
regression models using the basic functions in R [92], as well as the Pearson’s correlation
coefficient and three-way ANOVA tests [92], were employed.
3. Results
3.1. Changes in Gene Expression
The DGE analysis showed that, at 1 dpi, a downregulation of the AvBD10 gene (up to
1.92 times; p ≤ 0.01) was observed in all experimental subgroups relative to the negative
control S-I (SI Figure S1a). At this time point, the administration of phytobiotic Intebio®
in S-III also contributed to a downregulation of the AvBD10 gene as compared with S-I
(p≤ 0.01), but, in S-IV, it led to a higher expression of this gene than that in S-II (p < 0.05). At
7 dpi, an upregulation of this gene was found in all experimental subgroups in comparison
with S-I (p < 0.01; SI Figure S1b).
At 1 dpi, the IL6 gene was downregulated in S-II and S-III and upregulated in S-IV
(p < 0.05; SI Figure S1a). At 7 dpi, a downregulation of the IL6 gene was observed in S-II,
and there its expression was elevated in S-III and S-IV as compared with the two other
subgroups (p < 0.05; SI Figure S1b). Remarkably, S-II showed a downregulation of IL6 by
2.2 times at 1 dpi (p < 0.05) and by 2.7 times at 7 dpi (p < 0.05) relative to S-I. The IL8L1 gene
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was significantly upregulated in all the experimental subgroups—up to 15.3 times in S-IV
in comparison with S-I (p < 0.001; SI Figure S1a). At 7 dpi, the IL8L1 gene upregulation in
the experimental subgroups as compared with S-I was not as pronounced as at 1 dpi and
did not exceed 1.82 times (p < 0.01; SI Figure S1b).
A significant downregulation of the SLC5A1 gene was shown at 1 dpi in S-II and S-IV
relative to S-I (by 2.8 and 2.9 times, respectively; p ≤ 0.05; SI Figure S1a). At 7 dpi, the
expression level of this gene was restored, and there was even a significant upregulation in
S-II and S-IV (p ≤ 0.05; SI Figure S1b). The CA2 gene expression was significantly higher
at 1 dpi in all the experimental subgroups as compared with S-I (p < 0.05; SI Figure S1a).
At 7 dpi, this gene was also characterized by upregulation, with its sharp activation being
detected in S-II and S-III by 388.0 and 488.9 times, respectively, relative to S-I (p < 0.001; SI
Figure S1b). A significant decline in the CALB1 gene expression was found in S-IV (p < 0.05;
SI Figure S1a), while, at 7 dpi, there was a significant upregulation of this gene by 1.7 times
in S-II (p ≤ 0.05) and by 3.4 times in S-III in comparison with S-I (p < 0.01; SI Figure S1b).
The RARRES1 gene expression remained unchanged in all the experimental subgroups
at 1 dpi (SI Figure S1a). However, there was a significant upregulation of this gene at 7 dpi
in response to the Salmonella challenge in S-II as compared with S-I (p ≤ 0.05; SI Figure
S1b). At 1 dpi, the BPIFB3 gene regulation was significantly reduced in S-III (p < 0.05) and
increased in S-IV (p < 0.05; SI Figure S1a). By 7 dpi, a significant upregulation of this gene
was found in S-III and S-IV, reaching a factor of ~3100 in the latter (p < 0.05; SI Figure S1b).
The heat map in Figure 1 represents the generalized pattern of DGE observed during
the entire study in the negative control and experimental subgroups, depending on the
Salmonella challenge and/or Intebio® addition. Overall, a significant downregulation was
detected at 1 dpi and upregulation at 7 dpi for the AvBD10 gene in all subgroups, for IL6 in
S-III, for SLC5A1 in S-II and S-IV, and for BPIFB3 in S-III relative to S-I. At both 1 and 7 dpi,
the IL6 gene showed a significant downregulation in S-II, whereas there was a significant
upregulation of IL6 in S-IV, IL8L1 and CA2 in S-II to S-IV, and BPIFB3 in S-IV. The expression
of CALB1 in S-II and S-III and that of RARRES1 in S-II did not differ significantly from that
in S-I at 1 dpi and changed to an increased regulation at 7 dpi. In addition, the CALB1 gene
expression decreased at 1 dpi in S-IV was restored at the level of S-I at 7 dpi (Figure 1).
3.2. Dynamics of Blood Biochemical/Immunological Variables
By studying alterations in the 25 blood biochemical/immunological parameters in
layers, it was found that, at 1 dpi, there was a lower albumin (ALB) content in the challenged
subgroups S-II and S-IV than that in the nonchallenged subgroups S-I and S-III (p < 0.01;
SI Table S2). At 7 dpi, S-II was still characterized by the lowest ALB content (p ≤ 0.05; SI
Table S3).
The urea (UR) concentration was the lowest in S-II and the highest in S-IV at 1 dpi
in comparison with S-I, while, by 7 dpi, only S-II was different from S-I and superior to
all other subgroups, with almost similar patterns for the inter-subgroup differences being
identified for blood urea nitrogen (BUN) (p ≤ 0.05; SI Tables S2 and S3). The creatinine
(CR) content in the blood of all the studied subgroups was, at both time points, below
the normal reference range (SI Tables S2 and S3). However, S-III and S-IV showed, at
1 dpi, an increased CR content by 1.2 and 1.3 times, respectively, as compared with S-II
(p < 0.05), while this parameter was superior in S-II at 7 dpi relative to all other subgroups.
In addition, there was a lower ALT activity at 1 dpi in S-II and S-III, whereas, at 7 dpi, a
significantly greater ALT level was observed in S-II and S-IV than that in S-I (p ≤ 0.05). In
S-IV, this parameter exceeded the upper limit of the reference range for healthy birds and
was 2.7 times greater than that in S-III (p ≤ 0.001).
At 1 and 7 dpi, there was a lower content of aspartate aminotransferase (AST) in S-III
and S-IV fed Intebio® than that in S-I and S-II fed a normal diet (p < 0.05). On the other
hand, there was the greatest AST activity at 7 dpi in S-II relative to all other subgroups and
in S-IV as compared with S-III (p ≤ 0.05). A greater activity of alkaline phosphatase (ALP)
was demonstrated at 1 dpi in S-III and S-IV relative to S-I and S-II, while it lowered by
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7 dpi in S-II and S-III in comparison with S-I (p ≤ 0.05) and was deranged, being below the
reference range at both time points (SI Tables S2 and S3). It was also found that, at 1 dpi,
there was an elevation of the alpha amylase (AMY) content in S-II and S-IV as compared
with S-I and S-III, whereas its activity by 7 dpi was lower in S-II than that in S-I (p ≤ 0.05).
The GLUC concentration at 7 dpi in S-II to S-IV was also lower than that in S-I (p ≤ 0.05)
and was, on the whole, below the reference range (SI Tables S2 and S3).
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The total cholesterol (CHOL) concentration at 1 dpi was the lowest in S-II and S-IV
and the highest in S-III, while it did not differ at 7 dpi in S-II and S-III from that in S-I and
was superior in S-IV (p ≤ 0.05). The calcium total (CaT) level at 1 dpi was inferior in S-II
and S-IV to that in S-I and S-III (p ≤ 0.05). The phosphorus (PHOS) content was deranged
and lower at 1 dpi in the blood of challenged birds in S-II and S-IV by 1.4 and 1.6 times,
respectively, as compared with S-I and S-III (p < 0.05), whereas it decreased in S-II and S-III
(p ≤ 0.05) and grew in S-IV up to the level of S-I at 7 dpi. There was a greater bilirubin (BIL)
concentration at 1 dpi in S-III and S-IV and a lower one in S-II than that in S-I. At 7 dpi, it
was still the greatest in S-IV but declined in S-III below the BIL level in S-I (p ≤ 0.05).
A significant drop of the uric acid (URA) content in the blood was observed at 1 and
7 dpi in the challenged subgroups S-II and S-IV relative to the nonchallenged subgroups
S-I and S-III (p < 0.01). The SLA in S-II and S-III was greater at 1 dpi than that in S-I, and it
w s elevated in all the experimental subgroups relati e to S-I by 7 dpi (p ≤ 0.05). There
was an increased SBA level in S-IV by a factor of 1.3 at 1 dpi and by a factor of 1.7 at 7 dpi
in comparison with S-II (p < 0.05), whereas the i termediate levels of SBA were found out
in S-I and S-III. The BLA was lower at 1 dpi in S-II and S-III than that in S-I and S-IV and
changed t 7 dpi so that it was the lowest in S-II and the highest in S-IV as compared with
S-I (p ≤ 0.05).
The immunoglobulin activity also varied between the four subgroups nd two time
points. In particular, a declined IgA level i S-II and elevated one in S-III and S-IV were
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identified at 1 dpi, while it lowered in S-III and S-IV by 7 dpi to below the IgA activity in
S-I (p ≤ 0.05). The challenged S-II and S-IV were characterized by the lowest IgM activity
at 1 dpi, with its greater levels being found at 7 dpi in S-II to S-IV relative to S-I (p ≤ 0.05).
Additionally, a greater IgM level was determined at 7 dpi in S-IV relative to S-III (p < 0.01).
As for the IgG1 levels at 1 dpi, S-II and S-IV were also inferior to S-I (p ≤ 0.05), and S-III
was superior to the three other subgroups, while the declined IgG1 activity was observed
at 7 dpi in S-II and S-III in comparison with S-I and S-IV (p ≤ 0.05). The IgG2 activity was
lower in S-II and S-IV at 1 dpi and greater in S-II at 7 dpi as compared with S-I (p≤ 0.05). No
significant differences were found between the subgroups and time points in the contents
of the total protein and globulins.
Using a whole set of the studied biochemical/immunological parameters and plot-
ting the subgroup clustering, distinctive differences between the four subgroups were
demonstrated (SI Figure S2). As confirmed by two tree-building methods, the Ward’s
hierarchical agglomerative clustering, and UPGMA, S-III and S-IV were, at 1 dpi, the most
similar to each other, and S-II was the most distinguishing (SI Figure S2a,e), while the tree
topology of the four subgroups essentially changed by 7 dpi, so that the two challenged
and two nonchallenged subgroups grouped into two separate clusters (SI Figure S2b,f).
Normalization of the datasets led to a different Ward’s clustering pattern (SI Figure S2c,d),
showing the formation of the challenged and nonchallenged subgroup clusters already at
1 dpi.
An additional Pearson’s correlation coefficient test resulted in demonstrating a signifi-
cant positive correlation between the IL6 gene expression and SBA at 1 (r = 0.88; p < 0.01)
and 7 dpi (r = 0.76; p < 0.01), AvBD10 expression and BLA at 1 dpi (r = 0.9; p < 0.001), IL6
expression and BLA at 7 dpi (r = 0.81; p < 0.01), and IL8L1 expression and IgA activity
at 1 dpi (r = 0.71; p < 0.01). At 7 dpi, the expression of IL6 (r = 0.63; p < 0.05) and IL8L1
(r = 0.73; p < 0.01) positively correlated with the IgM activity in the blood.
3.3. Cecal Microbiome Diversity Characterization
To assess the alpha diversity of the cecal bacterial communities within the subgroups
studied, the mean values of the appropriate parameters, OTUs, and Shannon index were
calculated. As shown in Table 1, when the birds were challenged with SE and/or fed the
diet supplemented with Intebio®, there was no significant change in the number of OTUs
within one time point in any subgroup. There was a small but significant recession in the
Shannon index estimate at 1 dpi in S-IV as compared with S-I (p < 0.01). At 7 dpi, there
were no differences between the subgroups for both alpha diversity parameters; however,
the number of OTUs significantly lowered in all subgroups relative to 1 dpi (p < 0.05).
Table 1. Estimates of the alpha diversity parameters (M ±m).
Subgroups
OTUs Shannon Index
1 dpi 1 7 dpi 1 1 dpi 7 dpi
S-I 601.7 ± 44.8 a 385.7 ± 56.6 a 6.6 ± 0.02 a 6.4 ± 0.29 a
S-II 610.7 ± 35.8 a 428.3 ± 49.1 a 6.1 ± 0.39 a,b 6.5 ± 0.06 a
S-III 570.0 ± 25.2 a 390.7 ± 36.3 a 6.3 ± 0.13 a,b 6.3 ± 0.22 a
S-IV 521.3 ± 19.7 a 435.3 ± 16.2 a 6.1 ± 0.07 b 6.4 ± 0.21 a
1 Significant differences between operational taxonomic units (OTUs) at 1 vs. 7 days post-inoculation (dpi) within
each subgroup (p < 0.05). Subgroups: S-I (negative control), S-II (Salmonella enterica serovar Enteritidis (SE)
challenge), S-III (Intebio® intake), and S-IV (Intebio® intake + SE challenge). a,b Data within one column with no
common letters differed significantly (at p < 0.01). OTUs: operational taxonomic units.
To characterize the beta diversity differences between the four subgroups, a PCA was
performed (SI Figure S3). As can be seen from SI Figure S3a, the PC1 component allowed
to explain 48.57% of the variance in the 1 dpi dataset, while, respectively, 19.96% and 9.46%
of the variance were explained by PC2 and PC3, meaning that the first three principal
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components explained a total of 77.99% of the data information at describing the shifts that
occurred in the microbiome profiles of the four subgroups at 1 dpi.
The PCA-based comparison of the cecal microbiota diversity in the four subgroups (SI
Figure S3a) showed that, judging from the microbiome profiles, layers from S-IV and, to
some extent, S-II formed separate clusters. The greatest displacement along the PC1 axis
was observed in the samples from S-IV, while the other three subgroups were drawn to
the PC2 axis. Clustering in S-II and S-III was less pronounced than that in S-I and S-IV.
Apparently, the composition of chicken microbiomes in S-III also had more affinity with
that in S-I. The beta diversity of the cecal microbiota at 7 dpi can be described as shown in
SI Figure S3b. The cluster formation in S-II and S-III was less pronounced as compared with
S-I and S-IV. Subgroups IV, I, III, and II were consistently lined up along the PC1 axis with
the smallest clustering effect along two other axes. The clusters of S-I and S-III were close
to each other and occupied an intermediate position between the other two subgroups.
To achieve a better resolution of the inter-subgroup relationships, we proceeded
with the Ward’s hierarchical agglomerative clustering-based analysis of the chicken cecal
microbiomes at 1 and 7 dpi using squared Euclidean distances (Figure 2) that demonstrated
a clear separation of the subgroups into specific dendrogram clusters with the appropriate
significant AU/BP values, although the inter-subgroup distances within the clusters were
mainly quite small. In particular, at 1 dpi, the microbiomes of S-I and S-III merged into a
common cluster (at a ~0.5 distance; Figure 2a). S-IV was remotely allocated on a separate
branch at a considerable distance from the other subgroups. S-II also formed a separate
branch, but it clustered with S-II and S-III, being located at a much smaller distance (~1) to
them than S-IV. At 7 dpi (Figure 2b), the microbiomes of S-I and S-III were closest to each
other, combining in one cluster (at ~0.05), and then, S-II and S-IV grouped into the second
cluster (at ~3.5), while these two clusters were located much farther relative to each other.
Further, we performed Ward’s clustering by placing together the cecal microbiomes at
1 and 7 dpi (SI Figure S4) that generally confirmed the pattern of dendrograms built sepa-
rately for the two time points (Figure 2), the within-cluster distances between subgroups
being mainly smaller at one time point.
In Figure 3, diversity profiling of the cecal microbiota at the level of orders and higher
taxonomic ranks is presented in the form of a heat map. As seen from Figure 3, 13 phyla
and 24 orders of attributable microorganisms were identified in the cecal metagenomic
communities of the chickens.
At 1 dpi, microflora at the level of phyla was dominated by representatives of Firmi-
cutes and Bacteroidetes (Figure 3). Among the phylum Firmicutes, a significantly greater
proportion was determined for the order Clostridiales bacteria, with their contents ranging
between the minimum of 40.3% ± 3.61% and the maximum of 52.0% ± 4.39% (at p < 0.05
for a pairwise comparison between the subgroups). In chickens challenged with Salmonella
(S-II) and fed Intebio® (S-III), there were no significant changes in the number of these
microorganisms. A distinct elevation in the bacterial content of the order Clostridiales
was observed in S-IV (52.0 ± 4.39%) as compared with S-I (p < 0.05). Among the pre-
vailing microorganisms of the phylum Bacteroidetes, there were the order Bacteroidales
representatives (38.3% ± 3.85% to 48.3% ± 3.25%; p < 0.05). A greater number of these
microorganisms was found in S-II and S-III than that in S-I (p < 0.05). In contrast, there was
a decline in the contents of these bacteria in S-IV.
Bacteria from the phyla Firmicutes and Bacteroidetes were also abundant at 7 dpi (Figure 3).
The greatest percentage of the bacteria from the order Clostridiales was found in S-I
(42.0 ± 1.33%), their proportion being smaller in S-II (30.8% ± 0.53%; with p < 0.05 for the
differences between the subgroups). There was also a slight increase in the number of bac-
teria from the order Lactobacillales in S-III (5.5% ± 4.95%) as compared with the minimum
value in S-I (1.5% ± 0.26%), and an augmentation in Bacteroidales in S-II (60.5% ± 0.59%)
relative to S-III (49.7% ± 6.59%), but these differences between the subgroups were insignif-
icant. As evident in SI Figure S5a, among the order Bacteroidales, the most pronounced
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shifts in the number of bacteria at 1 dpi in the subgroups were observed for the dominant
species of Bacteroides barnesiae (p < 0.01).
The number of the genus Bifidobacterium representatives—among which, B. longum
dominated—was reduced in challenged chickens: by 10.5 times in S-II and by 12.5 times
in S-IV relative to S-I (p < 0.01; SI Figure S5a). There was a similar scaling down in the
contents of the order Lactobacillales, represented predominantly by the genus Lactobacillus
microorganisms, in S-IV relative to S-I (p < 0.05). The content of the genus Methanobrevibacter
archaea decreased in the cecum of layers by 1.2 times in S-II (p ≤ 0.05) and by 1.9 times
in S-IV (p < 0.05) as compared with S-I (SI Figure S5a). A growth in the content of the
genus Campylobacter bacteria occurred by 5.5 times in S-II (p < 0.05) and by 5.6 times in
S-IV (p ≤ 0.01) relative to S-I. In addition, we detected in the chicken cecal microbiota some
very small number of candidate division TM7 bacteria (up to 0.29% ± 0.02%; p < 0.05) and
candidate division WPS-2 representatives (up to 1.4% ± 0.06%; p ≤ 0.05).
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Figure 2. Ward’s hierarchical agglomerative clustering based on the chicken cecal microbiome
profiles at 1 (a) and 7 dpi (b) and using a matrix of squared Euclidean distances between objects.
Bootstra ping validation was performed using AU (approximat ly unbiased) p-values (%) and BP
(bootstrap probability) values (%) shown with red and green estimates, respectively. Clusters with
AU p-values greater than 95% are placed within red rectangles. Subgroups: I (negative control), II
(SE challenge), III (Intebio® intake), and IV (Intebio® intake + SE challenge).
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At 7 dpi (SI Figure S5b), the disappearance of the B. lo gum bacteria in S-II, S-III, and
S-IV was observed. In S-I, their number also dropped by about 100 times rel tive to 1 dpi
(p < 0.05). Differe ces between the subgroups in the content of the genus Lactobacillus
microor anisms wer insignificant. The genus Bacteroides was mainly represented by the
species B. b rnesiae and B. lebeius. There was a significant decline by 2.7 times in the
number of B. plebeius in S-III as compared with S-II (p < 0.05). The ord r Clostridiales
was represented by the genera Coprococcus, Dorea, Oscillospira, a d Ruminoc ccus that
demonstrated the greatest variability in the subgroups. No significant differences between
the subgroups n the e era C prococcus, Rumino occus, and Oscillospira were found. Th e
were 3.7 times more representatives of the genus Dorea in S-III in comparison with S-II,
which had their smallest number (p < 0.05).
3.4. Effects of SE and Intebio® on Egg Productivity
An analysis of the egg production traits over a 27-day egg-laying period revealed
significant differences between their m an values in the four subgroups of laying hens
(Table 2). In particular, S-I was significantly inferior in egg we (64.94 g) to S-III (66.10 g;
p < 0.05) and S-IV (66.33 g; p < 0.01) nd superior in egg mass to S-II (547.54 vs. 479.19 g;
p < 0.05). S-II had lower mean values than S-IV by egg weight (64.29 vs. 66.33 g; p < .01)
and was r l ti e t S-III by the number of laid eggs (7.48 vs. 8.56; p < 0.05) and egg mass
(479.19 vs. 564.81 g; p < 0.01). S-III exceeded S-IV in the number of eggs (8.56 vs. 7.52;
p < 0.05) and in egg mass (564.81 vs. 498.86 g; p < 0.05).
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Table 2. Mean values of egg production traits by subgroup (M ±m).
Subgroups 1 Egg Weight, g No. of Laid Eggs Egg Mass, g
S-I 64.94 ± 1.91 a 8.44 ± 1.76 a 547.54 ± 111.03 a
S-II 64.29 ± 2.43 a,c 7.48 ± 2.10 a,b 479.19 ± 134.37 b
S-III 66.10 ± 2.19 b,c 8.56 ± 1.40 a,c 564.81 ± 91.2 a,c
S-IV 66.33 ± 1.71 b 7.52 ± 2.10 a,b 498.86 ± 141.17 a,b
1 Subgroups: S-I (negative control), S-II (SE challenge), S-III (Intebio® intake), and S-IV (Intebio® intake + SE
challenge). a–c Data within one column with no common letters differed significantly (at p < 0.01).
Additionally, a post-peak egg production recession was analyzed using daily egg
mass values in the subgroups. Based on the decreased rate, it was found that there was
a rather slower diminution of egg productivity in laying hens fed Intebio®, especially in
S-III, in comparison with S-I and S-II (see, for details, SI File S2). A comparison of the
dependences in S-I and S-II (Figure SI2-1b) suggested a stable decline in their egg mass
values throughout the entire 27-day period. The comparison of S-I and S-III (Figure SI2-1c)
showed that, starting from about the middle of the observation period, S-III was superior to
S-I. When comparing S-I and S-IV (Figure SI2-1d), it was noted that S-IV gradually aligned
with S-I (control), while S-III had a better egg production recession rate than that in S-IV
(Figure SI2-1e).
3.5. Mathematical Analyses Combining All Studied Characters
Ultimately, a resumptive analysis was conducted using the PCA method at the two
time points, 1 and 7 dpi, taking into account all groups of characters measured in the
four subgroups of laying hens (SI Figure S6 and Figure 4), including DGE; the blood bio-
chemical/immunological parameters; cecal microbiome profiles; and three egg production
traits (mean egg weight, number of laid eggs, and egg mass). Visualization using the PCA
enabled us to describe the multivariate datasets, show the interrelations of the characters
studied, and identify the key factors in this experiment at the two time points. To describe
the complex of these characters, the first three principal components (PC) were considered.
In two-dimensional graphs, the first principal component (PC1) at 1 dpi (SI Figure S6a)
was most affected by such blood biochemical/immunological factors as concentrations of
ALB, PHOS, and URA, and the immunoglobulin activity (IgG1, IgG2, and IgM), as well
as the egg productivity traits, i.e., mean egg weight and, to a lesser extent, number of laid
eggs and egg mass. The serum BLA negatively correlated with SLA had the greatest impact
on PC2. PC3 was affected by IgA, BIL, and CR (SI Figure S6b).
The nonchallenged subgroups S-I and S-III and the challenged subgroups S-II and S-IV
occupied mutually opposite positions along the PC1 axis (SI Figure S6a). Probably, PC1
was associated with the factors responsible for the development of an infection process at
1 dpi, defining the lowered content of serums ALB, PHOS, and URA and immunoglobulins
IgM, IgG1, and IgG2, as well as a decline in the egg production traits. Using PC2, one can
observe that S-I and S-III were spread along the PC2 axis. The SLA in S-III was higher
than that in S-I. PC3 was likely to reflect the interactions of two factors, SE challenge, and
administration of phytobiotic Intebio®. The PC3 factors did not have a significant impact
on S-I and S-III. S-IV differed from S-II by a greater content of IgA, BIL, and CR.
At 7 dpi, there was a change in the limiting factors (SI Figure S6c,d), with PC1 being
mainly affected by UR, BUN, CR, and SBA. The mutual arrangement of S-II and S-IV
relative to the PC3 axis, as compared with 1 dpi, altered to the opposite one. S-II was
distinguished by a high content of UR, BUN, and serum CR. Probably, PC1 reflected a
reserve capacity of the hen’s organism. The greatest contribution to PC2 at 7 dpi was made
by the contents of ALT, BIL, and IgM. S-IV differed from S-I and S-III by greater values of
these characters. The negatively correlated with each other ALP (that was in S-III lower
than in S-I) and SLA contributed the most to PC3, while PC3 had a lesser effect on S-II
and S-IV.
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tion and Intebio® supplementation, each of which contributed to the shift in the level of 
this immunoglobulin. The following optimal and reliable multicharacter model was de-
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Figu e 4. Principal components analysis of the amples by a complex of cha act rs represented as
three-dimensional graphs (one point corresponds to one hen, the mean values for each subgroup
being shown as the fourth point of the larger diameter) at 1 (a) and 7 dpi (b) in the subgroups: I
(negative control), II (SE challenge), III (Intebio® intake), and IV (Intebio® intake + SE challenge).
By the complex of characters in layers of the four subgroups, their comparisons based
on PCA clustering in two- (SI Figure S6) and three-dimensional graphs (Figure 4) showed
that conjugate changes in the studied characters at 1 dpi in chickens from S-I and S-II led to
their separation into single remote clusters. There was a rather detached and, at the same
time, close location of S-III and S-IV that lay on the same plane formed by the axes PC1
a d PC2, sugg sting that, by the complex of characteristics, S-III ha a significant affinity
with S-IV relative to the main factors of PC3, includin the IgA, BIL, and CR c ntents
(Figur 4a).
At 7 dpi, clusteri g on the basis of the studied charac er sets also had fairly distinct
outli es f r all four subgroups (Figure 4b). Hereby, S-III sh wed, on a thre -dimensional
graph, the maximum distance fr m other subgroups, while S-II and S-IV were located in
proximity to e ch other. S-I was also located at a somewhat remote distance from the other
subgroups.
Since one of the stablished factors that influenced PC1 at 1 and 7 dpi was the IgM
activity, we employed a regression model to determine the degree of the effect of Intebio®
intake on the IgM level. The IgM activity was closely related to a number of its explaining
predictors as follows: content of ALP, AST, and CHOL, along with the factors of SE
infection and Intebio® supplementation, each of which contributed to the shift in the level
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of this immunoglobulin. The following optimal and reliable multicharacter model was
developed, with all statistical coefficients being significant (p = 0.007 for intercept, p < 0.001
for predictors, adjusted R2 = 0.9339 for this model, F statistic = 66.03, and p = 6.06 × 10−11
for the general significance level of the model):
X = −1.671 + 0.624A + 0.350B + 0.007C− 0.007D + 1.146E (1)
where X is the IgM level, A is the Intebio® intake factor, B is the SE infection factor, C is the
AST level, D is the ALP level, and E is the CHOL content.
In the above model, the interaction of factors was not taken into account, and each
predictor contributed a certain share due to the appropriate coefficient value. Considering
Formula (1), the IgM activity depended on a constant equation member meaning a shift
equal to −1.671. The diet factor coefficient (0.624) was greater than that for the SE infection
factor (0.350), reflecting a greater increase of the IgM value in the subgroups fed the Intebio®
supplement vs. normal diet than that in the subgroups infected with SE vs. nonchallenged
hens. Additionally, growth in the IgM content was slightly positively associated with AST
(0.007) and, especially, with CHOL (1.146), whereas it had a somewhat negative relationship
with ALP (−0.007), meaning a slight decrease in the ALP level while the IgM activity was
elevated. AST and ALP had the lowest coefficients, suggesting their smaller contribution
to the IgM level. The largest factor was the CHOL content (1.146), and its effect on the IgM
level alteration could be expressed more decidedly in contrast to a more discreet transition
due to the SE infection and Intebio® intake factors.
Based on the above multicharacter model (1) for IgM predictors, and using the Pear-
son’s correlation coefficient test, we determined a significantly close correlation between
CHOL and IgM (r = 0.70; p < 0.01); however, no significant correlation was established
between the other predictors and IgM.
As a result of the three-way ANOVA tests, we found that the factors of SE challenge
and phytobiotic intake had a significant effect on the levels of IgM, CHOL, AST, and ALP
(p < 0.05). The factor of the two time points in relation to the blood indices measured had a
significant effect on the IgM, CHOL, and AST (p < 0.05) but did not affect the ALP activity
(p > 0.05).
4. Discussion
4.1. Gene Expression Changes in Response to SE and Phytobiotic
As was shown in previous studies (e.g., in broilers [93]), the most pronounced alter-
ation in the expression level of genes associated with the immune system was found 1 day
after the challenge with Salmonella. In the present study, we also investigated the immune
response of laying hens to SE via DGE at 1 dpi, as well as at the 7-dpi time point, in order
to observe the long-term challenge effects. For this purpose, we selected some key genes
related to immunity (AvBD10, IL6, IL8L1, and BPIFB3); the transport of nutrients and ions
in the intestine; and metabolism (SLC5A1, CA2, CALB1, and RARRES1). Moreover, it was
desirable in terms of tissue-specific expression and for comparative purposes to juxtapose
these chicken genes with their homologs in mammals (including humans), since most of
these genes were shown to be expressed, for example, in the human GIT [51], which we
also discuss below where appropriate.
As a result of our studies, it was shown that the expression of the AvBD10 gene associ-
ated with the synthesis of gallinacin-10 and the anti-inflammatory immune response [94]
was downregulated at 1 dpi in all experimental subgroups relative to S-I (up to 1.92 times;
Figure 1 and SI Figure S1a). Previously, a reduction of the AvBD10 expression in the cecum
by 2.04 times was observed in an experiment on the infection of chickens with S. enterica
serovar Pullorum as compared with the nonchallenged subgroup [95]. Similarly, when the
chickens were infected with Salmonella, a lower defensin gene expression was detected in
susceptible birds sensitive to Salmonella infection in comparison with resistant ones, and
differences in the level of immunity-related DGE between the susceptible and resistant
chicken lines were demonstrated [96]. In our experiment, an upregulation of the AvBD10
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gene was found at 7 dpi in all the experimental subgroups relative to S-I (Figure 1 and
SI Figure S1b). In all likelihood, this gene is involved in providing a resistance to SE in
the studied laying hens, but its activation occurred later than 1 dpi. Interestingly, S-III
and S-IV fed Intebio® also demonstrated, at 1 dpi, a significant AvBD10 downregulation
in comparison with S-I. Despite this, the level of this gene expression in S-IV was signifi-
cantly higher than that in S-II, suggesting some positive effect of Intebio® on the AvBD10
expression in challenged hens. This seemed to be a positive phenomenon relevant to
the bacteriostatic [43] and anti-inflammatory response [94] exhibited by this gene. The
anti-inflammatory effect of the EOs was also noted in other studies [16,17].
We also found an upregulation of the IL6 gene at 1 and 7 dpi in S-IV relative to S-I,
S-II, and S-III (Figure 1 and SI Figure S1). S-II showed a significant IL6 downregulation at
both 1 and 7 dpi relative to S-I. Apparently, this gene in our experiment was significantly
suppressed in response to the SE challenge in S-II, whereas the dietary supplementation
with Intebio® in S-IV could have a positive effect on the elevated IL6 expression level
and, presumably, on immunity as a whole. IL6 is known to play a central role in defense
mechanisms, hematopoiesis, and acute phase reactions and is part of the innate protective
immune responses [97–99]. On the other hand, the hyperproduction of proinflammatory
cytokines such as IL6 may have negative effects in animals [100–102]. The biological signif-
icance/role of IL6 has been widely studied in mammals [103], including humans [51]. In
particular, this homologous gene is known to be highly activated in the human gall bladder,
appendix, and esophagus, while being expressed in other GIT organs [51]. Therefore, we
may consider this homologous gene expression as one of the important protective elements
of the chicken cecum, as well as in the digestion of amniotes, in general.
As for IL8L1, a gene associated with chemokine synthesis involved in signaling be-
tween immune cells [35], a drastic elevation in its expression level was observed at 1 dpi in
all the experimental subgroups in comparison with S-I. There was also a significant IL8L1
upregulation in S-III and S-IV relative to S-II, suggesting that this could be because of the
Intebio® intake and may point out a positive role of the phytobiotic in strengthening the
protective barriers of the hen’s body. The proinflammatory cytokine IL8 is a mediator of
the inflammatory process [104]. Although inflammation can be indicative of an immune
response that inhibits the infection process, increased levels of proinflammatory mediators
can also have negative consequences, including tissue damage and decreased productiv-
ity [105]. Previously, when infecting Ross 308 broilers with SE, a significant increase in the
expression level of chemokines IL8L1 (CXCLi1) and IL8L2 (CXCLi2) was identified in the
cecal tonsils (by 3.13 times) in comparison with nonchallenged birds, as well as infection
with other tested Salmonella serovars [106]. In addition, in another experiment [93], there
was an upregulation of genes associated with the synthesis of CXC chemokines, including
IL8L1, in the small intestine of chickens of two lines (fast-growing line A and slow-growing
line B) in response to an infection with SE. At 7 dpi (Figure 1 and SI Figure S1b), we also
found a significant IL8L1 upregulation in all the experimental subgroups, although it was
less pronounced than at 1 dpi and did not exceed 1.82 times as compared with S-I. Other
studies [107,108] also reported a growth in the number of cytokines and immune proteins
such as IL6, IL8, IL1B, IL12, IL17, IL18, IL22, IL23, IFNG, and LITAF after the infection
of chickens with Salmonella, which, to some extent, echoes our results. The homologous
human IL8 gene is also highly expressed in the appendix (with the second-highest level
among the studied organs and tissues), gall bladder, and liver [51], suggesting its important
defensive role in the GIT of higher vertebrates.
We identified, at 1 dpi, a significant SLC5A1 downregulation in the challenged sub-
groups relative to S-I: by 2.8 times in S-II and by 2.9 times in S-IV (Figure 1 and SI Figure S1a).
SLC5A1 is a membrane protein, a sodium-dependent GLUC cotransporter, which is part of
the GLUC carrier family, and is a high-affinity Na+/GLUC transporter and ensures almost
all uptake of the carbohydrates in the small intestine [52]. The transport of GLUC and
galactose through small intestinal enterocytes provides an effective ionic homeostasis and
is the first step in the absorption of carbohydrates and feeds [109]. It is likely that intestinal
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infection caused by Salmonella and resulting from the interaction between various virulence
factors of this pathogen and host defense mechanisms can alter the transport of nutrients
in the GIT, aggravating inflammation and causing diarrhea and malabsorption [29,30]. The
downregulated SLC5A1 expression we observed in challenged hens may be associated with
the above negative intestinal effects related to Salmonella infection. By 7 dpi, however, the
SLC5A1 expression level was restored and even upregulated in both challenged subgroups:
S-II and S-IV (Figure 1 and SI Figure S1b). In humans, high levels of this homologous gene
expression were detected under normal conditions—most of all, in the duodenum, small
intestine, and gall bladder—whereas it was also expressed to a lesser degree in the colon
and appendix [51].
Our study demonstrated a small but significant CA2 gene upregulation at 1 dpi in
all the experimental subgroups as compared with S-I (Figure 1 and SI Figure S1a). This
gene is associated with the synthesis of carbonic anhydrase 2, an enzyme that is involved
in CaCO3 formation and, as a consequence, influences eggshell calcification [53]. In farm
animals and poultry subject to intensive selection, especially for traits associated with
growth, development, reproduction, and the composition of harvested products [110], one
might expect extra selection pressure—in particular, on the expression of the CA2 gene
related to productivity in layers. In humans, the homologous CA2 gene is also highly and,
most of all, activated in the stomach, colon, and duodenum; gall bladder and liver; and, to
some extent, in the appendix and small intestine [51]. At 7 dpi, the CA2 gene regulation
was highly activated in S-II and S-III relative to S-I (Figure 1 and SI Figure S1b). To the
best of our knowledge, we discovered, for the first time, these effects of Salmonella and
phytobiotic intake on the CA2 expression in the chicken cecum, any relevant literature data
being absent.
There was another interesting observation in this study regarding the CALB1 gene
which was significantly upregulated at 7 dpi in S-III relative to S-I, while its downregulated
expression in S-IV at 1 dpi was restored to the level of S-I by 7 dpi (Figure 1 and SI
Figure S1a,b). This may be evidence of a positive effect of the Intebio® intake on the
expression of this gene associated with the synthesis of calbindin, a protein involved in
calcium transport, associated with the mechanical properties of eggshells in chickens [111]
and slightly expressed in the human appendix [51]. The dynamics of this gene expression in
response to Salmonella infection observed in our study on adult layers was inconsistent with
the data on CALB1 downregulation in the livers of five-month-old broilers at 10 dpi [47]
and in the cecum of newly hatched layer chicks at four dpi [112], so this controversial
CALB1-related data requires further investigation.
We reported, for the first time, the RARRES1 gene expression in the chicken cecum.
There was an upregulation of this gene at 7 dpi in response to the Salmonella challenge in S-II
as compared with S-I (Figure 1 and SI Figure S1b). RARRES1 is associated with the synthesis
of ovocalyxin-32, a 32-kDa protein, which is part of the eggshell matrix that provides the
developing embryo with protection against colonization by pathogenic microflora [54,113]
and is related to the thickness of the mammillary shell layer [114]. This gene was originally
identified as a target gene induced by the synthetic retinoid tazarotene (AGN 190168) in
human skin wound cells [115]. There was also evidence of a surprisingly high expression
of this homologous gene in the human appendix, more than in any other organ or tissue,
while being also expressed in the colon, gall bladder, and small intestine [51]. RARRES1
is predicted to have metalloendopeptidase inhibitor activity [116] and was also shown to
inhibit the growth of B. subtilis, suggesting its antimicrobial activity and contribution to
the natural protection of the chick embryo [57]. In addition, the RARRES1 gene may be a
potential molecular marker associated with higher rates of egg production and affecting
the performances of layers [117]. We have not found in the literature any data on the
expression of the RARRES1 gene in the chicken cecum and its differential regulation in
response to infection with SE, which represents a significant novelty of our results. The
new information on RARRES1 expression in the GIT we report here, data by [51], and
future studies may lead to an extended understanding and revision of the functions that
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this gene and its secreted product execute in the body of higher vertebrate animals and
humans.
A novel finding was also obtained in our study with regards to the cecal expression
of the BPIFB3 gene encoding the synthesis of ovocalyxin-36, a 36-kDa eggshell protein.
Ovocalyxin 36 is secreted in the oviducts, and its expression is usually regulated during
the active calcification phase of the shell [55,118]. The BPIFB3 expression was also found in
various parts of the GIT of healthy broiler chickens, including the cecum [119]. Here, we
observed a significant downregulation of this gene in the cecum of layers at 1 dpi in S-III
and its upregulation in S-III and S-IV at 7 dpi (Figure 1 and SI Figure S1a,b). Considering the
molecular evolution for a number of important homologous genes in amniotes, including
humans, this gene was found to be highly expressed, for example, in the salivary gland at
the second-highest level across various organs and tissues [51], so further investigation of
the BPIFB3 functions would be needed.
Analyzing the effect of the phytobiotic on the activation of immunity- and metabolism-
related genes, we would suggest that, at 1 dpi, the adaptive response to the Salmonella
challenge and Intebio® intake in S-IV included the increased expression level of such genes
as AvBD10, IL6, IL8L1, and BPIFB3 as compared with S-II. Based on our results, we can also
suggest that, by 7 dpi, the long-term effects of the SE challenge in S-II was likely to lead
to activation of the genes AvBD10, IL8L1, SLC5A1, CA2, CALB1, and RARRES1 involved
in immunity, transport, metabolism, and digestion. In a few cases (SI Figure S1b), 7-dpi
upregulation mediated by the SE challenge and/or supplement in S-II, S-III, and S-IV
reached a factor of ~400 to ~500 (CA2) and even ~3100 (BPIFB3), which was comparable
to the maximal expression of various genes in response to Salmonella infection in other
studies [112].
4.2. Blood Biochemical/Immunological Variables as Affected by SE and Intebio®
As follows from our study results, there was a decline in the ALB content in the blood
of layers at 1 dpi in both of the challenged subgroups S-II and S-IV in comparison with
the nonchallenged subgroups S-I and S-III, as well as its lowest level in S-II at 7 dpi (SI
Table S2). ALB is the main protein in the chicken blood serum, its fraction being the major
reservoir of the protein. It also plays an important role in maintaining the colloid osmotic
pressure and acid–base balance, because it works as a carrier of small molecules such as
vitamins, minerals, hormones, and fatty acids [120,121]. The decreased ALB content was
probably due to inflammatory process caused by Salmonella infection, and it was previously
reported that ALB reduction (hypoalbuminemia) can be caused by GIT diseases [122].
We demonstrated, at 1 dpi, lower levels of UR and BUN in challenged hens of S-II in
comparison with S-I and the appropriate increased levels in S-IV (SI Table S2), suggesting a
negative effect of SE and a positive one of Intebio®. The CR content in the blood of all the
studied subgroups was deranged and below the reference values at both 1 and 7 dpi (SI
Tables S2 and S3). However, at 1 dpi, we found a greater CR level by 1.2 times in S-III as
compared with S-I and by 1.3 times in S-IV relative to S-II, which may be indicative of a
positive effect from the use of the additive. The fact is that CR is the end product of creatine
metabolism, most CR being synthesized in the liver and transported to skeletal muscles.
The CR concentration in the blood is fairly constant, reflecting the muscle mass condition,
since a lower CR would be observed, along with a reduced muscle mass. Additionally,
this blood biochemical index is used for the additional assessment of kidney function in
poultry [120,121]. At 7 dpi, the concentrations of UR, BUN, and CR were at the same level
in S-I, S-III, and S-IV, and only S-II showed a significant rise.
In our experiments, the pathological process caused by SE was accompanied by a
significant growth at 7 dpi in the ALT activity in both of the challenged subgroups S-II
and S-IV (SI Table S3). Moreover, it exceeded in S-IV the upper limit of the reference range
for healthy birds and was 2.7 times higher than that in S-III. In clinical biochemistry, the
function of transaminases ALT and AST is to catalyze the transfer of the amino group of
amino acids to keto acid. In mammals, when the membranes of liver cells are disintegrated
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due to cell damage or metabolic changes, ALT and AST are released into the blood plasma.
In general, the degree of increased ALT activity in the blood is proportional to number of
damaged hepatocytes. However, these enzymes in birds are not specific for determining
the liver function, and alterations in their contents do not necessarily correlate with liver
damage [120,121]; therefore, the interpretation of change in avian blood enzyme activity
may be different. Nonetheless, it was previously suggested that augmented ALT levels in
response to Salmonella infection may be related to the ability of this pathogen to colonize the
liver, which causes damage to its cells [59,123]. Our data on the elevated ALT levels in SE-
challenged chickens was in agreement with previous observations in other studies [23,58].
Such an elevation was demonstrated in the SE-challenged subgroup (SE) of day-old ISA
Brown chicks [23] at four and 18 dpi in comparison with three other subgroups: fed
an EO-based sage extract (S), SE-challenged and fed the extract (SSE), and the negative
control (C).
As our study demonstrated, there was a reduction of the AST content in both S-III and
S-IV fed Intebio® as compared with S-I and S-II at both 1 and 7 dpi, while we observed
in challenged chickens at 7 dpi the maximal growth of AST in S-II, as well as a greater
AST level in S-IV relative to S-III (SI Tables S2 and S3). A significant elevation in the AST
activity was also shown at four dpi in ~six-month-old White Leghorn layers inoculated
intramuscularly with Salmonella Typhimurium (ST) [124]. These findings would suggest a
positive effect of phytobiotic intake and a negative one of Salmonella infection in the bodies
of birds, taking into account that AST may be a nonspecific marker of the pathology of
hepatocytes in poultry [120,121].
Combining the data on levels of UR, BUN, CR, ALT, and AST at both time points, we
can see that the activity of the two aminotransferases was significantly lower at 1 dpi in
the challenged S-II birds, with the concentrations of UR, BUN, and CR being also lower.
However, by 7 dpi, the activity of the two enzymes, ALT and AST, in this subgroup were
significantly elevated, while the levels of UR, BUN, and CR also grew. This might be
indicative of an expected metabolic response to the SE challenge progression. ALT and AST
mediate the involvement of amino acids into catabolic pathways and facilitate the reduction
of such major protein metabolism products such as UR and CR. In other studies (e.g., in
broiler chicks [125]), ALT and AST lowered their activity in response to a stress factor (e.g.,
a supplementation with silver nanoparticles [125]). This caused lower concentrations of
UR and CR, suggesting a disturbed protein catabolism.
We found a significant elevation of ALP at 1 dpi in S-III and S-IV fed the supplement
and its drop by 7 dpi in all the experimental subgroups relative to S-I (SI Tables S2 and S3).
A similar lowering of ALP activity was determined at four dpi in subgroups SE, S, and SSE
in comparison with C [23]. Previously, a significant decline in the ALP level was also seen in
other studies, e.g., at four dpi in White Leghorn hens infected with ST [124], in cockerels in
response to the Newcastle disease virus [126,127], and in broiler chicks subjected to a stress
factor (silver nanoparticles [125]). However, we were unable to find any published data on
the ALP activity at 1 dpi in response to Salmonella and/or phytobiotics, so its increase in
chickens fed Intebio® seems unclear, and further investigation would be wanted. Since the
ALP level in S-III was at 7 dpi lower than that in S-I, this may be indicative of the protective
effect of phytobiotics on tissues and parenchymal organs in healthy birds.
In both of the challenged subgroups S-II and S-IV, there was an elevation at 1 dpi in the
blood levels of the digestive enzyme AMY as compared with the nonchallenged subgroups
S-I and S-III, which probably reflected the activation of the carbohydrate metabolism in
response to SE, taking into account that AMY is produced by the pancreas and is involved
in the breakdown of starch and glycogen to GLUC. By 7 dpi, the AMY activity was reduced
in S-II, which also had a declined GLUC level. A consimilar decreased GLUC concentration
in response to ST was found in Leghorn fowls at four dpi [124]. In our study, there were also
lower GLUC concentrations at 7 dpi in S-III and S-IV. Likewise, reduced GLUC levels were
detected at four dpi in subgroups SE and SSE in comparison with C, although subgroup S
showed the same GLUC content as C [23].
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Challenged hens in S-II and S-IV demonstrated, at 1 dpi, a lower CHOL concentration.
Similarly, a reduced CHOL level in response to a parenteral ST inoculation was identified
in two broiler strains at 0.5 dpi [128] and in Leghorn chickens at four dpi [124]. Our further
observations showed that, by 7 dpi, the CHOL content was restored in S-II at the negative
control level or was a bit higher in S-IV.
The calcium content was found to be at lower levels in the challenged subgroups S-II
and S-IV at 1 dpi, which could also be related to a downregulation of the CALB1 gene
involved in calcium transport (SI Figure S1a). At 1 dpi, the PHOS content in the blood
decreased in the challenged subgroups S-II and S-IV by 1.4 and 1.6 times, respectively, as
compared with the nonchallenged subgroups S-I and S-III, and it was lower in S-II by 7 dpi,
as well. This seems to be quite natural, since a decline in the PHOS content in birds is
usually observed with loss of appetite or bowel disease [120,121].
A dropped BIL concentration was previously seen in subgroups SE, S, and SSE at
four dpi and its elevated levels in the same subgroups at 18 dpi relative to C [23]. We found
a different pattern of changes in the BIL amount, though at two different time points, as
follows: a downswing in S-II and growth in S-III and S-IV at 1 dpi and decline in S-III and
increase in S-IV at 7 dpi. The effects of SE and EOs on the BIL levels in the chicken body
would require further examination.
Unlike mammals that produce UR as a result of the breakdown of amino acids,
the main product of the metabolism of nitrogen-containing compounds in birds is URA.
We identified that there was an abrupt fall in the URA content at 1 and 7 dpi in both
of the challenged subgroups S-II and S-IV relative to the nonchallenged subgroups S-I
and S-III. This observed phenomenon is consistent with other studies showing that a
protein deficit in the diet leads to a diminution in the serum URA concentration [120,121].
Probably, a Salmonella infection in chickens may cause a reduction in protein digestibility
and absorption.
The SLA usually declined in challenged poultry [129–132], although we determined
an opposite effect at the two time points in S-II, S-III, and S-IV, suggesting a need for further
exploration of the SLA in chickens infected with SE and/or fed EOs.
There was a 1.5-fold decline in the SBA level in S-II as compared with S-I, while no
SBA decrease was identified in S-IV. This might give evidence of a positive effect of the
phytobiotic intake in birds, since SBA is an integrative factor for the natural resistance of
the humoral type, suggesting an ability of the blood to “self-clean”. A drop in the SBA
index may be due to a profound impairment of the immune system and serves as an
unfavorable prognostic indicator [120,121]. Based on the Pearson’s correlation coefficient
test, we identified a significant direct relationship between the IL6 gene expression and
SBA in hens at 1 and 7 dpi.
The correlation analysis also showed a significant direct relationship of the gene
expression of AvBD10 (at 1 dpi) and IL6 (at 7 dpi) with BLA. This correlation between
BLA and the expression of immunity/inflammation-related genes seems to be meaningful,
since an increase in the level of β-lysines, cationic serum proteins produced by platelets
and demonstrating bactericidal activity against aerobic spore-forming bacteria, is usually
revealed in the acute phase of inflammatory processes [120,121].
In the challenged subgroups S-II and S-IV, we observed, at 1 dpi, a lower content of all
the studied immunoglobulin classes: IgA, IgM, IgG1, and IgG2, which are glycoproteins
playing an important role in the functioning of innate immunity and produced in response
to an exposure to antigens of bacteria, viruses, micromycetes, protozoa, etc. At 7 dpi, there
was a rise in the levels of IgM and IgG1 in S-IV as compared with S-III. Interestingly, the
correlation analysis revealed the presence of a significant direct relationship between the
IL8L1 gene expression and IgA content at 1 dpi and between the gene expression of IL6
and IL8L1 and IgM activity.
If we examined an entire set of the biochemical/immunological indices, the challenged
S-II subgroup was, at 1 dpi, the most different from the other subgroups, whereas S-IV was
closer to S-III, forming a cluster of these two subgroups fed Intebio®, which was then com-
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bined with S-I (SI Figure S2a,e), suggesting a positive effect of Intebio® administration at
the acute SE challenge phase. The further progression of immune and metabolic responses
to Salmonella led, at 7 dpi, to somewhat similar blood biochemical/immunological changes
in the challenged and nonchallenged subgroup clusters (SI Figure S2b,f).
Thus, the assessment of blood biochemical/immunological parameters characterizing
the levels of the metabolic processes and adaptive metabolic homeostasis in laying hens
suggested significant negative shifts in the metabolism due to SE challenge and a positive
effect of the administration of the phytobiotic Intebio®. The expression levels of the
genes associated with immunity correlated with some biochemical/immunological blood
parameters that reflect the activation of the chicken immune system.
4.3. Effects of SE and Intebio® on Cecal Microbiome Profiles
Judging from the alpha biodiversity parameters of the cecal microbial communities
(Table 1), the SE challenge and/or Intebio® intake did not affect the number of OTUs in any
of the subgroups within one time point. No differences were also demonstrated in the total
number of OTUs when comparing the microbiota profiles in the cecum of male ISA Brown
chicks infected with SE after being hatched vs. nonchallenged control birds [133]. However,
for assessing the biodiversity of communities, one should take into account not only such
a descriptive metric as the number of species (OTUs) but, also, their relative abundance
or “evenness”. The Shannon diversity index takes into account both the species richness
and “uniformity” of OTUs [134], and, as noted in Table 1, there was a slight decrease in
the Shannon index at 1 dpi in S-IV as compared with S-I, meaning some lowering in the
biodiversity [135]. Thus, the simultaneous SE challenge and phytobiotic administration
had some impact on the relative abundance and “evenness” of the species but not on
their number.
The comparison of the beta diversity in the cecal microbiota of laying hens from the
four subgroups using the PCA showed that, at 1 dpi, the individual microbiome profiles
in S-IV, as well as, to some extent, those in S-II, were separated into distinct clusters,
suggesting a certain difference in the structure of microflora in these subgroups relative to
the nonchallenged S-I and S-III hens (SI Figure S3a). Interestingly, the greatest displacement
along the axis of the first principal component (PC1) was shown for the S-IV samples,
whereas the other subgroups gravitated towards the PC2 axis. This would additionally
provide evidence of a relatively unique microbiome composition in S-IV. Additionally, S-III
and S-IV had a greater microbiome variability than the two other subgroups, meaning
that the greatest homogeneity within a subgroup was observed among the samples of
S-I and S-II. Moreover, the composition of individual microbiomes in the nonchallenged
S-III had more affinity with S-I. By 7 dpi, a definite change occurred in the subgroup
clustering pattern, reflecting a shift in their microbiota profiles (SI Figure S3b). These
results demonstrated a definite effect of the Salmonella infection on the alterations in the
composition of the cecal microbiome in adult laying hens from 1 dpi to 7 dpi. Previously,
in the study of bacterial profiles in male chicks reared for a few weeks after hatching [133],
there was no obvious PCA-based clustering of SE-challenged and nonchallenged groups,
as well as turns in the microbiota profiles after infection, suggesting that those data [133]
are not directly comparable to our study.
In addition, we produced Ward’s clustering of the cecal microbiome profiles at the two
time points (Figure 2 and SI Figure S4). At 1 dpi, the microbiomes in the nonchallenged
subgroups S-I and S-III merged into a common cluster that was then joined by S-II, with
the inter-subgroup distances being very small (Figure 2a and SI Figure S4). This could
illustrate small differences in the bacterial profiles between the nonchallenged subgroups
S-I and S-III, on the one hand, and the SE-challenged S-II, on the other, suggesting that 1 dpi
would not be a sufficient period for Salmonella in S-II to develop a pronounced effect on the
microflora composition. In contrast, S-IV subjected to two factors (Intebio® and SE) stood
out separately and at a considerable distance from the other subgroups. Thus, judging
from the results of both PCA and Ward’s clustering, the combination of the two factors in
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S-IV had, at 1 dpi, a pronounced effect on its cecal microbiota profile. By 7 dpi, the tree
topology essentially altered, reflecting the progression of SE infection that caused a more
evident and quite similar shift in the microflora profiles in S-II and S-IV in comparison
with the cluster of nonchallenged subgroups S-I and S-III (Figure 2b and SI Figure S4).
We suggest that the changes we observed in the profiles of the intestinal microbiota in
chickens are self-consistent, since it is known [134,135] that the infection of the organism
with S. enterica leads to an active synthesis of antimicrobial metabolites in the intestines,
such as proteases, reactive oxygen species, nitric oxide radicals, and chelators. Many of
these antimicrobial agents can cause a reduction in the number of certain microorganisms.
As a result of assessing the diversity of the metagenomic community in the cecum
of laying hens at the level of orders and higher taxonomic ranks (Figure 3), we detected
13 phyla of attributable microorganisms. The microflora at the phylum level was dominated
by Firmicutes and Bacteroidetes. Previously, a 16S rRNA gene sequencing-based study
showed [136] that representatives of the phyla Firmicutes and Proteobacteria accounted
for more than 90% of the analyzed sequences in male chicks infected with ST at four days
old, which might differ from our results. However, differences in the compared profiles
of the intestinal microbiome could be associated with different ages in the studied birds,
as well as with different diet compositions and the use of antibacterial drugs. Specifically,
a certain selective effect of the antibiotic virginiamycin used in the compound feed (SI
File S1) on the presence of some representatives in the microflora might be seen in our
experiment, suggesting a competitive exclusion of some microorganisms and a boosted
colonization with the others. In our opinion, the prevalence of Firmicutes and Bacteroidetes
bacteria in the microbiome that we showed here can be explained by the fact that these
taxa mainly include anaerobic forms, and their abundance is self-consistent due to a lower
redox potential in the intestine.
In our study, a significant proportion among the Firmicutes phylum were the order
Clostridiales bacteria (40.3% ± 3.61% to 52.0% ± 4.39%). The Salmonella challenge of chick-
ens in S-II did not significantly affect the number of these microorganisms, whereas an
evident increase in the bacterial content of the order of Clostridiales was observed in S-IV ex-
posed to SE and the phytobiotic as compared with S-I. A significant abundance of these mi-
croorganisms in the lumen of chicken intestines was previously reported [137]. Pathogenic
bacteria such as Clostridium tetani (tetanus agent), C. botulinum (botulism pathogen), and
C. perfringens (gas gangrene agent) are often found among the order Clostridiales bac-
teria [138]. Additionally, among the order Clostridiales representatives, there are many
microorganisms (families Lachnospiraceae, Eubacteriaceae, Ruminococcaceae, etc.) that
produce cellulase during the metabolism [139]. This enzyme catalyzes the hydrolysis of
β-1,4-glycosidic bonds in cellulose delivered with feed, with the formation of GLUC or
cellobiose, taking an active part in the digestion process. In our experiments, there was no
significant elevation in S-IV (as compared with S-I) in the content of the genus Clostridium
bacteria—among which, pathogenic forms are often present. In this regard, an uplift
in other bacteria from the order Clostridiales in S-IV may suggest a positive role of the
phytobiotic in restoring the normal composition of the intestinal microbiome.
Among the phylum Bacteroidetes microorganisms, the order Bacteroidales bacteria
were abundant in the chicken intestines in all subgroups (38.3% ± 3.85% to 48.3% ± 3.25%),
with a rise in the number of these microorganisms in S-II and S-III relative to S-I and
the decreased contents of these bacteria in S-IV. The Bacteroidales order microorganisms
uncultivated on nutrient media were increasingly recognized as the predominant repre-
sentatives of the intestinal microbiota in chickens [140,141]; however, the nature of their
interactions with the host in birds has not been fully uncovered. In mice and humans, it
was shown [142] that these microorganisms can be both commensals and pathogens. It is
known [143] that they play the role of symbionts in the GIT of humans, animals, and birds,
metabolizing carbohydrates, including starch, to acetate, succinate, and isovalerate. It has
been repeatedly noted that some representatives of this taxon, e.g., Bacteroides fragilis, are
often the predominant microorganisms in polymicrobial infections of humans. Moreover,
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the synthesis of β-lactamase by some of them contributes to an increased antibiotic resis-
tance to β-lactam antibiotics. Bacteremia caused by B. fragilis has been reported, with an
associated human mortality rate of 27%. Many bacteria of the Bacteroidales order [142]
have a SpeB homolog, a peptidase capable of cleaving many immunologically relevant
proteins. In particular, the periodontal pathogen Prevotella intermedia has a homolog in-
terpain A that takes part in the inhibition of the immune response through complement
degradation [144].
A peculiar and controversially abruptly fall in number of the genus Bifidobacterium
representatives (among which, B. longum dominated) (SI Figure S5a) in the challenged
subgroups S-IV (by 12.5 times) and S-II (by 10.5 times) relative to S-I. The representatives
of this taxon have a number of useful properties for the body, including antagonistic
properties against pathogens, the synthesis of water-soluble vitamins, the digestion of
plant oligo- and polysaccharides, the suppression of the production of potentially toxic
metabolites, and the modulation of the host immunity [145]. In this regard, the decline in
the number of Bifidobacteria in the challenged subgroups may be indicative of dysbiotic
disorders in the composition of the intestinal microflora.
We also detected a similar pattern of a reduced content of the order Lactobacillales
representatives (mainly, the genus Lactobacillus microorganisms) in S-IV in comparison
with S-I. Many bacteria of this taxon produce bacteriostatic and bactericidal compounds
like organic acids, bacteriocins, and others [146], inhibiting microbes that can be pathogenic
to chickens, such as Escherichia coli, Salmonella spp. [147], Clostridium perfringens [148],
Campylobacter jejuni [149], and others. Our data on a reduction in the number of the order
Lactobacillales representatives due to the infection of chickens with Salmonella contradict
a certain other study [133] on infecting chickens with SE, which showed no significant
changes in the number of microorganisms, with the exception of the Lactobacillaceae family
representatives, the contents of which, in contrast to our results, grew.
Interestingly, there was a lessening in the content of methanogenic archaea of the
genus Methanobrevibacter in the cecum of hens in S-IV (by 1.9 times) and S-II (by 1.2 times) as
compared with S-I (SI Figure S5a). The presence of methanogenic archaea in the GIT lumen
of birds is known [150], but their ecological role in the body of birds has not been studied.
In the example of cattle, whose methanogenic symbionts play a significant role in environ-
mental pollution, it was shown that, in the rumen, these microorganisms exclusively use
H2, CO2, and, to a lesser extent, formate as methanogenic precursors, despite the fact that
methanol; acetate; and mono-, di-, and trimethylamines also represent potential substrates
for fermentation [151]. Hydrogen removal from the rumen occurs mainly as a result of
methane formation reactions, the latter being the only energy-generating process in these
bacteria that requires the presence of cofactors [152]. It was found that the transformation
of carbon dioxide to CH4 is of great importance for the effective course of fermentation in
the rumen, since it prevents the accumulation of reducing equivalents [153]. However, this
process causes significant environmental damage, since, on average, about 20% of the total
methane emissions into the atmosphere are due to methanogenesis in the digestive tract of
ruminants [154].
It was previously demonstrated that, in the rumen of cattle, amylolytic bacteria synthe-
sizing propionate are able to compete with methanogens for the use of hydrogen [155]. In
our experiment, a lowered content of methanogenic archaea of the genus Methanobrevibacter
in the chicken cecum in S-II and S-IV could be associated with an elevation in the number
of amylolytic microorganisms of the order of Bacteroidales due to competitive exclusion.
Among the order Bacteroidales bacteria, the most pronounced variation in the amount
was found between the subgroups for the dominant species Bacteroides barnesiae (SI Figure S5a).
This species is a typical representative of the order Bacteroidales and a common inhabitant
of the intestinal lumen of mammals and birds [156].
In our research, an increase in the content of Campylobacter bacteria was noted in
S-IV (by 5.6 times) and S-II (by 5.5 times) relative to S-I, which may be associated with a
reduced amount of the order Lactobacillales representatives that synthesize antimicrobial
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substances. This could be indicative of dysbiotic disorders in the intestinal microbiome
as a result of an infection with SE, since pathogens such as Campylobacter jejuni and E. coli
are often found among bacteria of the genus. Despite the fact that birds, as a rule, show
resistance to infection by these pathogens, some representatives of Campylobacter spp. are
the main cause of foodborne gastroenteritis in humans [157].
In addition, among the microflora we examined in the cecum of hens, unidentified
candidate division TM7 bacteria (up to 0.29% ± 0.02%) and candidate division WPS-2
(phylum) (up to 1.4% ± 0.06%) were found in very small quantities. There are studies
showing the presence of the candidate division TM7 bacteria in the contents of the GIT
of birds [158], including chickens [159]. However, the role of these microorganisms in the
intestines of birds was unclear. A relationship was found between the increased amount of
TM7 bacteria in the human intestine and inflammatory bowel diseases [160], which may
suggest their negative role in the host. As for the WPS-2 microorganisms, the presence of
these bacteria was previously observed in the feces of Strigops habroptila parrots [161]. In
the lumen of the chicken cecum, these microorganisms were discovered by us for the first
time. The role of these bacteria has not yet been disclosed. In our experiment, there was a
significant decline in the contents of these microorganisms in S-II and S-III, whereas their
numbers remained unchanged in S-IV relative to S-I.
Overall, we can suggest that, although we did not observe any significant direct effects
of Intebio® on preventing or reducing the infection of Salmonella, the diet supplementation
with the phytobiotic could be related to changes in the whole microbiota profile and
separate microbial taxa.
4.4. Egg Production Traits and Effects of SE and Intebio®
One of the major aims of the study was to identify differences between the subgroups
(control and experimental ones) in the mean egg weight and other performance traits
during the experiment period, both before and after the challenge with SE. Herewith, the
physiological period should be taken into account, i.e., the peak of egg production that the
chickens were at. During this period, the biological limit of productivity is observed in
birds; therefore, the information obtained in the experiment made it possible to track the
effectiveness of the phytobiotic and the effect of the SE challenge on these traits.
Over a 27-day period of the experiment, we revealed significant differences between
the subgroups (control and experimental ones) in the mean egg weight and other egg
productivity traits.
The minimum rate of decline in egg production was observed in S-III layers fed the
Intebio® additive, suggesting that the phytobiotic properties had a positive effect on their
performance. Obviously, the use of Intebio® also had a certain positive effect in S-IV hens
infected with Salmonella and fed the supplement. Due to slowing down the decreasing rate
in the egg production function, the productivity of chickens in this subgroup leveled out in
relation to the control (S-I) by the end of the 27-day laying period (Figure SI2-1d).
Overall, significant differences were found between the experimental subgroups in
terms of egg productivity—specifically, egg weight—with a negative effect of infection in
the SE-challenged hens and a positive one when adding phytobiotics to the chicken diet.
4.5. Interplay between Treatments and Studied Characters
Using the PCA technique (SI Figure S6 and Figure 4), we established in this study on
SE infection and supplement of the chicken diet with phytobiotics that the main significant
determinants were such biochemical/immunological blood factors as the content of serums
ALB, PHOS, UR, BUN, BIL, CR, ALT, SBA, SLA, and BLA and immunoglobulins (IgA,
IgM, IgG1, and IgG2), as well as egg production traits. Probably, their observed variations
reflected the processes due to SE infestation to the greatest extent, suggesting that these
factors responded to infection at a faster rate. The phytobiotic administration and SE
challenge had a strong influence on the formation of individual clusters in two-dimensional
PCA graphs using a complex of the studied characters (SI Figure S6).
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Thus, by applying a PCA, it was feasible to visualize the acute phase of the pathological
process at 1 dpi and its further progression by 7 dpi and reveal the distinctive factors
affecting S-III and S-IV fed the phytobiotic supplement.
The set of determinants we considered in the course of the PCA analysis and iden-
tified as the significant ones confirmed our assumption about the positive effects of the
phytobiotic treatment on the layers. Egg productivity was found to be closely linked to
the biochemical/immunological blood composition. The infestation with the pathogen
affected all systems of the chicken body.
The results of the Ward’s clustering-based analysis of the microflora composition
(Figure 2 and SI Figure S4), as well as the implementation of the PCA method using
the complex of all the studied characteristics (SI Figure S6 and Figure 4), showed that
the arrangement of the subgroups in distinct clusters could occur due to the two key
treatment factors, i.e., SE infection and the phytobiotic supplement. Each produced cluster
was described by a number of unique characteristics. Judging from the comprehensive
correlation study, a change in the level of IL8L1 gene expression positively correlated with
a change in the level of IgA activity, for the genes IL6 and IL8L1 with IgM activity, and for
the genes AvBD10 and IL6 with BLA. Regardless of the use of the phytobiotic, there was a
decline in the levels of IgA, IgM, IgG1, and IgG2 at 1 dpi. Thus, the observed clusters of
the studied subgroups were dynamically dependent on the time factor associated with the
development of the infestation process and the immune response of the bird’s body. At
1 dpi, the key biochemical/immunological blood factors were the serum levels of IgA, IgM,
IgG1, IgG2, ALB, PHOS, URA, BLA, SLA, BIL, and CR. At 7 dpi, the other factors became
important, including the contents of UR, BUN, CR, SBA, ALT, BIL, IgM, ALP, and SLA.
The phytobiotic effect on the factors of the immune response could be seen, such that the
IgG1 level was elevated by 7 dpi in S-IV, and the level of CR in the blood was higher in
S-III and S-IV.
We also looked closer into the IgM changes by applying the multicharacter model (1).
These changes, at first glance, might reflect the development of an immune response by
7 dpi. However, as demonstrated in Formula (1), the coefficient for the Intebio® admin-
istration factor was 0.624 or almost 1.8 times higher than that for the SE infection factor
(0.350), and this may suggest a greater contribution of Intebio® to the IgM level than that
of SE infection. Additionally, we determined that a significantly close correlation between
CHOL and IgM is consistent with the data on the relationship of CHOL with IgM and
IgG in the serum found by other authors [162], while the CHOL level was linked to other
serum biochemical indicators and the visceral fat of chickens, considering breed and gender
differences as important factors for variations in the blood serum parameters [163].
5. Conclusions
Our multifaceted investigations suggest that the challenge with SE and the admin-
istration of the phytobiotic Intebio® based on essential oils in the diet of laying hens had
both a depressing and an activating effect on the expression of certain studied genes and
performances. DGE was observed at both 1 and 7 dpi for genes associated with immunity,
the transport of molecules/ions, and the metabolism in the intestine. We also suggested
parallels with the mammal/human tissue-specific expression of homologous genes as
evidence of existing evolutionary conservation in gene functions between remote higher
vertebrate taxa.
We observed the effects of the pathogen infection and phytobiotic supplementation
on the microbiome profiles in the cecal contents and biochemical/immunological blood
parameters, including such indicators of the immune system activity of birds as the level of
SBA, BLA, and immunoglobulins. As we showed, the SE challenge negatively affected the
state of the GIT microbiome and the level of the metabolism in hens, whereas the Intebio®
intake in the infected hens could cause a pronounced shift in the microbiota composition in
the cecum at 1 dpi. The supplementation of the layer diet with the phytobiotic suggested a
certain positive effect on the state of the body’s metabolic activity and an elevation of their
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adaptive potential reflected by the activated expression of some genes in both challenged
and nonchallenged birds. Significant differences were found between the subgroups in
terms of the egg production traits, with a negative effect of SE infection on them in the
challenged subgroup and a positive effect of the phytobiotic specifically on egg weight.
Judging from a comprehensive assessment of the produced data, the tested feed
additive was not toxic, while having the potential to create a certain mobilizing status
of the immune system due to the activation of a number of responsible genes, probably,
even before infection. The supplemental effects were also reflected in the changes in
the biochemical/immunological blood indices and cecal microflora profiles and, as a
consequence, in maintaining the egg production traits at the levels of healthy layers.
Supplementary Materials: The following are available online at https://www.mdpi.com/2076-2
615/11/2/360/s1: SI Table S1: Gene-specific primers for assessing the expression of eight chicken
genes. SI Table S2: Blood biochemical/immunological parameters in laying hens at 1 dpi. SI Table
S3: Blood biochemical/immunological parameters in laying hens at 7 dpi. SI Figure S1: Relative
quantification (RQ) of the expression of the eight genes associated with immunity, transport, and
metabolism in laying hens at 1 (a) and 7 dpi (b) in the subgroups. SI Figure S2: Subgroup clustering
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